In this ISSUE

Virtual Clinical Trials: The Future of Patient Engagement?

Modeling and Simulation in Clinical Trials: Real Potential or Hype?

Gastroparesis Treatment: What’s Coming up Next

Regulatory Authorities, EMA

Danger: EMA Reputation at Risk

As the EMA celebrates its 2017 highlights, the new year brings deeper challenges for the agency—including preserving the credibility of its patient-first mission.
... /Read more/

Scientific Advice with Regulators – An Essential Tool in Early Drug Development
Live Webcast- Europe: Thursday, March 29, 2018 at 3:00pm CEST, North America: Tuesday, April 17 at 11:00am EDT

mHealth

Navigating the Use of Digital Health in Virtual Trials

In this interview, Dr. Michelle Longmire, CEO of Medable, will discuss her perspective on the advancements of digital health in clinical trials.
... /Read more/

Calendar

/ EFGCP Annual Conference 2018 2/20-2/21 /

/ Clinical Trial Budgeting & Forecasting 2/22 /

/ EU Clinical Trial Regulation Summit 3/06-3/07 /

/ ADF 2018 - Abuse Deterrent Formulations Summit 3/13-3/14 /

The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT

Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy
Live Webcast: Tuesday, February 20 at 11:00am EST

Clinical Trial Future

The Future of Clinical Trial Modernization: What’s to Come in 2018

2017 has been an exciting year for the clinical trials industry on many fronts, driven by new methods, regulation, and technology, but what is to come in 2018?
... /Read more/

The Rare Disease Revolution
On Demand

Learn more

Software and Services

Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics

This article discusses real-time data capture and analytics in clinical trials.
... /Read more/

Research Reveals a Need for Evolution in Randomization and Trial Supply Management (RTSM) Technology
On Demand

Learn more

Analytical Model

Janssen Develops Analytical Vendor Oversight Model

Kristy Galante, Director Process and Infrastructure of External Alliances at Janssen, recently spoke about a novel vendor oversight model at ExL’s 8^th Clinical Quality Oversight Forum, and will expand on the model in this interview.
... /Read more/

Ask the editor

Lisa Henderson
Editor in Chief
[email protected]

Advertise

Todd Baker
Group Publisher
[email protected]

website / blog / advertise / subscribe